Prot #M24-064: AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing ABBV-400 Monotherapy to LONSURF (Trifluridine and Tipiracil) plus Bevacizumab in Subjects with c-Met Over-Expressed Refractory Metastatic Colorectal Ca

Project: Research project

Project Details

StatusActive
Effective start/end date11/6/24 → 11/6/27

Funding

  • AbbVie Inc. (Prot #M24-064)